Someday we will get a offer like onxx got. Just don't know when (or ever). If deal is for real, may spark other big pharma to make offers.. They need to keep their pipelines full.. May be get a little bump on Monday because of this? LOL
The contrast is that Onyx has more actual sales and has candidates in what you might call the "general cancer" market. There's a reasonable chance that more research effort might increase market size quickly. The stock price reflects the nearer time scale of potential sales increases, so the bids don't look completely out of proportion to the existing market capitalization.
Incyte could look a lot more like Onyx if the pancreatic CA trial succeeds. No promises about either the trial result or about market reaction to it.
well depends on what happens in the short term to onxx, to me there are 3 other companies that COULD BECOME ( i am not saying it will) targets, pcyc,sgen,incy.......incy trailing the other big moves today in pcyc and sgen